{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:49:39Z","timestamp":1792792179895,"version":"4.5.0"},"reference-count":18,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pharmacyclics LLC, an AbbVie Company"},{"name":"American Society of Hematology\u2013Harold Amos Medical Faculty Development Program fellowship","id":[{"id":"https:\/\/ror.org\/02nw48b86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2019,3,21]]},"DOI":"10.1080\/10428194.2018.1512710","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T05:45:27Z","timestamp":1538459127000},"page":"1000-1005","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":29,"title":["Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib"],"prefix":"10.1080","volume":"60","author":[{"given":"Jacqueline C.","family":"Barrientos","sequence":"first","affiliation":[{"name":"CLL Research and Treatment Program, Zucker School of Medicine at Hofstra\/Northwell, Lake Success, NY, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Byrd","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hillmen","sequence":"additional","affiliation":[{"name":"Department of Haematology, The Leeds Teaching Hospitals, St. James University Hospital, Leeds, UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Zhou","sequence":"additional","affiliation":[{"name":"Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joi","family":"Ninomoto","sequence":"additional","affiliation":[{"name":"Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danelle F.","family":"James","sequence":"additional","affiliation":[{"name":"Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Diego, Moores Cancer Center, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-362624"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-527853"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.122"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215637"},{"key":"CIT0006","volume-title":"(Ibrutinib) prescribing information","author":"IMBRUVICA\u00ae","year":"2018"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.7906"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70335-3"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00465-9"},{"key":"CIT0010","first-page":"427","volume":"130","author":"Burger JA","year":"2017","journal-title":"Blood"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-386417"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.316"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89904"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Hallek M, Cheson BD, Catovsky D, et\u00a0al. Response assessment in chronic lymphocytic leukemia treated with novel agents causing an increase in peripheral blood lymphocytes [e-letter]. Blood. 2012. http:\/\/www.bloodjournal.org\/content\/111\/12\/5446\/tab-e-lett ers?sso-checked=true#clarification-of-iwcll-criteria-for-a-partial-response-to-therapy.","DOI":"10.1182\/blood-2007-06-093906"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-606038"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.175"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2018.1512710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:05:31Z","timestamp":1662163531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2018.1512710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3,21]]}},"alternative-id":["10.1080\/10428194.2018.1512710"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2018.1512710","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}